comparemela.com
Home
Live Updates
Eluminex Biosciences Announces Completion of Initial Enrollment in Part A of the CLARITY Study Evaluating a Human Recombinant Collagen-derived (rhCIII) Biosynthetic Cornea (EB-301) : comparemela.com
Eluminex Biosciences Announces Completion of Initial Enrollment in Part A of the CLARITY Study Evaluating a Human Recombinant Collagen-derived (rhCIII) Biosynthetic Cornea (EB-301)
/PRNewswire/ -- Eluminex Biosciences today announced the completion of clinical enrollment in Part A (N=5) of a two-part pivotal study (CLARITY) evaluating a...
Related Keywords
China ,
California ,
United States ,
San Diego ,
Wuhan ,
Hubei ,
Suzhou ,
Jiangsu ,
American ,
Eluminex Biosciences ,
Mingchang Zhang ,
Charles Semba ,
China Jiangsu Medical Product Agency ,
American Society Of Cataract ,
Corneal Surgery At Wuhan Union Hospital ,
Initial Part ,
American Society ,
Refractive Surgery Annual ,
Jiangsu Medical Product Agency ,
Greater China ,
Refractive Surgery ,
Professor Mingchang Zhang ,
Corneal Surgery ,
Wuhan Union Hospital ,
Chief Medical Officer ,
San Francisco ,
comparemela.com © 2020. All Rights Reserved.